Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71

Status Completed

Clinical Trial Summary

This study is a multicenter, case-control phase IV clinical trial to evaluate the effectiveness of the EV71 vaccine. About 40000 children in the town aged 6-35 months will be recruited and vaccinated with EV71 vaccines, which account for 20-40% of the children aged 6-35 months in the areas. The subjects will be vaccinated with EV71 vaccine at day 0 and day 28. Other children of appropriate age in the town will choose voluntarily whether or not to be vaccinated with EV71 vaccine. All children's vaccination of EV71 vaccines will be recorded in the study areas and the coverage rate of EV71 vaccine in the town will be calculated. The vaccination is expected to complete before the epidemic peak of HFMD. Surveillance of HFMD cases caused by EV71 will be conducted in hospitals of the study areas for 10-12 months, which cover a whole HFMD epidemic period. Throat and anal swabs will be collected from children with a clinically diagnosed HFMD for typing of human enteroviruses tested by PCR. The HFMD cases with EV71 positive will be recruited as cases, while those with EV71 negative will be recruited as test-negative controls. Besides, for each EV71-associated HFMD cases, the investigators will select 4 community controls mateced with each case for age, sex and residence.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03582761
Study type	Interventional
Source	Jiangsu Province Centers for Disease Control and Prevention
Contact
Status	Completed
Phase	Phase 4
Start date	May 1, 2019
Completion date	May 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06063057` - Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial	Phase 1/Phase 2
Completed	`NCT04133584` - The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine	Phase 4
Completed	`NCT03241030` - Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial	Phase 2
Completed	`NCT01255124` - Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children	N/A
Completed	`NCT03873740` - Immunogenicity and Safety of Two Different Commercial EV71 Vaccines	Phase 4
Completed	`NCT05637229` - A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
Recruiting	`NCT06146088` - Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine	Phase 4
Active, not recruiting	`NCT06209398` - Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine	Phase 4
Recruiting	`NCT01145664` - A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease	N/A
Recruiting	`NCT01175915` - A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Completed	`NCT01182532` - A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Completed	`NCT03281174` - Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine	N/A
Completed	`NCT03903926` - Efficacy Trial of a Commercial EV71 Vaccine	Phase 4
Completed	`NCT02001233` - A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
Completed	`NCT03909074` - Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months	Phase 3
Completed	`NCT01769794` - Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study	N/A
Recruiting	`NCT01182025` - A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Recruiting	`NCT06263439` - Surveillance of HFMD in Pediatric Outpatients
Not yet recruiting	`NCT05397587` - An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)	Phase 4
Completed	`NCT04111432` - Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines	Phase 4